Adenosine therapy for supraventricular tachycardia during pregnancy

Our results suggest that the use of intravenous adenosine for termination of maternal SVT during the second and third trimester of pregnancy is safe and effective. The development of fetal bradycardia following administration of multiple antiarrhythmic drugs emphasizes the importance of fetal heart...

Full description

Saved in:
Bibliographic Details
Published in:The American journal of cardiology 1995-03, Vol.75 (7), p.521-523
Main Authors: Elkayam, Uri, Goodwin, T. Murphy
Format: Article
Language:English
Subjects:
Adenosine
Adenosine - therapeutic use
Adult
Arrhythmia
Biological and medical sciences
Bradycardia
Cardiac arrhythmia
Cardiac dysrhythmias
Cardiology. Vascular system
Drug development
Drug therapy
Electrocardiography
Female
Fetuses
Heart
Heart rate
Humans
Intravenous administration
Medical electronics
Medical research
Medical sciences
Pregnancy
Pregnancy Complications, Cardiovascular - drug therapy
Tachycardia
Tachycardia, Supraventricular - drug therapy
Therapy
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Our results suggest that the use of intravenous adenosine for termination of maternal SVT during the second and third trimester of pregnancy is safe and effective. The development of fetal bradycardia following administration of multiple antiarrhythmic drugs emphasizes the importance of fetal heart rate monitoring during acute antiarrhythmic therapy. Further study is necessary to determine the safety of adenosine use during the first trimester of pregnancy.
ISSN:0002-9149
1879-1913
DOI:10.1016/S0002-9149(99)80597-9